Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments

MT Newswires Live

2024/12/11

Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.

The company has also teamed up with AMILI which provides advanced gut microbiome screening.

The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.

Patients can see their results within seven days.

Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2490001917"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490001917\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2490001917?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-11 11:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490001917","market":"us","top_or_hot":-1,"title":"Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments","media":"MT Newswires Live","content":"<html><body><p> Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.</p><p>The company has also teamed up with AMILI which provides advanced gut microbiome screening.</p><p>The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.</p><p>Patients can see their results within seven days.</p><p>Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Manulife Singapore Partners with Guardant Health to Provide Cancer Treatments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nManulife Singapore Partners with Guardant Health to Provide Cancer Treatments\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2024-12-11 11:58</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.</p><p>The company has also teamed up with AMILI which provides advanced gut microbiome screening.</p><p>The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.</p><p>Patients can see their results within seven days.</p><p>Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票月供概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2490001917","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490001917","pubTimestamp":1733889503,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.The company has also teamed up with AMILI which provides advanced gut microbiome screening.The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.Patients can see their results within seven days.Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","MFC":"宏利金融","BK4162":"人寿与健康保险","BK4588":"碎股"},"translate_title":"宏利新加坡与Guardant Health合作提供癌症治疗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MFC":1},"content_text":"Manulife Singapore has partnered with oncology treatment company Guardant to provide its customers access to the Guardant360 liquid biopsy test, according to a company release on Tuesday.The company has also teamed up with AMILI which provides advanced gut microbiome screening.The Guardant360 test carries out genomic profiling of advanced solid cancers and identifies biomarkers through blood samples.Patients can see their results within seven days.Through the partnership with AMILI, Manulife will be able provide its customers with personalized insights to improve their immunity, nutrition and brain health.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}